Dergiler / Turkish Journal of Pharmaceutical Sciences / 2020 / Cilt: 17 - Sayı: 5

Design and In Vitro Characterization of Orally Disintegrating Modified Release Tablets of Naproxen Sodium

Naproksen Sodyumun Ağızda Dağılan Değiştirilmiş Salım Tabletlerinin Tasarımı ve İn Vitro Karakterizasyonu

Sayfa
486–491
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The drug release from the tablets was sustained for 2 h by incorporating a suitable amount of Soluplus®.Conclusion: This study examined the use of Soluplus® (a novel solubilizer) for the first time as a release modifier of API from tablets.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to prepare orally disintegrating, slow release tablets of naproxen sodium for prompt onset and sustained action required in many types of acute pain.Materials and Methods: Tablet formulations containing varying concentrations of croscarmellose sodium (a superdisintegrant) and Soluplus® (as release modifier) were prepared by wet granulation method using a single punch tablet machine.
📊
Temel Bulgular & Veri:A disintegration time of tablets <30 s was achieved by selecting an optimum concentration of croscarmellose sodium.
💡
Sonuç & Katkı:The drug release from the tablets was sustained for 2 h by incorporating a suitable amount of Soluplus®.Conclusion: This study examined the use of Soluplus® (a novel solubilizer) for the first time as a release modifier of API from tablets.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of this study was to prepare orally disintegrating, slow release tablets of naproxen sodium for prompt onset and sustained action required in many types of acute pain.Materials and Methods: Tablet formulations containing varying concentrations of croscarmellose sodium (a superdisintegrant) and Soluplus® (as release modifier) were prepared by wet granulation method using a single punch tablet machine. The prepared granules were evaluated for their bulk properties and the tablets were evaluated for hardness, disintegration time, and drug release profiles.Results: The results showed that the granules so prepared have good flow and compressional properties. A disintegration time of tablets <30 s was achieved by selecting an optimum concentration of croscarmellose sodium. The drug release from the tablets was sustained for 2 h by incorporating a suitable amount of Soluplus®.Conclusion: This study examined the use of Soluplus® (a novel solubilizer) for the first time as a release modifier of API from tablets.

Abstract

Amaç: Bu çalışmanın amacı, birçok akut ağrı tipinde gerekli olan hızlı ve sürekli etki için ağızda dağılan, yavaş salımlı naproksen sodyum tabletlerinin hazırlanmasıdır.Gereç ve Yöntemler: Farklı konsantrasyonlarda kroskarmeloz sodyum (bir süper dağıtıcı) ve Soluplus® (salım değiştirici olarak) içeren tablet formülasyonları, tek zımbalı tablet makinesi kullanılarak ıslak granülasyon yöntemi ile hazırlandı. Hazırlanan granüller, yığın özellikleri açısından değerlendirildi ve tabletler, sertlik, parçalanma süresi ve ilaç salım profilleri açısından değerlendirildi.Bulgular: Bu şekilde hazırlanan granüllerin iyi akış ve sıkıştırma özelliklerine sahip olduğu tespit edildi. Optimum kroskarmeloz sodyum konsantrasyonu seçilerek <30 saniyelik bir tablet parçalanma süresine ulaşıldı. Tabletlerden ilaç salımı, uygun miktarda Soluplus® eklenerek 2 saat süreyle sürdürüldü.Sonuç: Bu çalışmada, Soluplus®’un (yeni bir çözücü) ilk kez tabletlerden API’nın salım değiştiricisi olarak kullanımını araştırıldı.

🔖

Bu Makaleye Atıf Yap

HUSSAIN, A., MISBAH, M., ABBAS, N., IRFAN, M., ARSHAD, M. S., SHAMIM, R., BUKHARI, N. I., MAHMOOD, F. (2020). Design and In Vitro Characterization of Orally Disintegrating Modified Release Tablets of Naproxen Sodium. Turkish Journal of Pharmaceutical Sciences, Cilt: 17 - Sayı: 5, 486–491. https://ajindex.com/articles/403559

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Shojaei, AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci. 1998;1:15-30.
  2. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder Int. J Pharm. 2004;278:423-433.
  3. Hirani JJ, Rathod DA, Vadalia KR. Orally disintegrating tablets: a review trop. J Pharm Res. 2009;8:61-172.
  4. Mahal RK, Dr. Samein LH, Shehab M. Formulation and in-vitro evaluation of orodispersible tablet. Int J Pharm Sci Res. 2015;4:689-696.
  5. Sharma D, Kumar D, Singh M, Singh G, Rathore M. Fast disintegrating tablets: a new era in novel drug delivery system and new market opportunities. JDDT. 2012;1:74-86.
  6. Reddy KR, Mutalik S, Reddy S. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation. AAPS Pharm Sci Tech. 2003;4:480-488.
  7. Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS Pharm Sci Tech. 2003;4:18-23.
  8. Sagar N, Goswami L, Kothiyal P. Orally disintegrating tablets: a review. Int J Apl Res. 2012;3:1222-1228.
  9. Chang RK, Xiaodi G, Burnside BA, Couch RA. Fast-dissolving tablets. Pharm tech. 2000;24:52-58.
  10. Fini A, Bergamante V, Ceschel GC, Ronchi C, de Moraes CAF. Fast dispersible/slow releasing ibuprofen tablets. Eur J Pharm Biopharm. 2008;69:335-341.
  11. Wei Q, Yang F, Luan L. Preparation and in vitro/in vivo evaluation of a Ketoprofen orally disintegrating/sustained release tablet. Drug Dev Ind Pharm. 2013;39:928-934.
  12. Amaral MH, Lobo JS, Ferreira D. Effect of hydroxypropyl methylcellulose and hydrogenated castor oil on naproxen release from sustained-release tablets. AAPS Pharm Sci Tech. 2001;2:14-21.
  13. Badgujar B, Mundada AS. The technologies used for developing orally disintegrating tablets: a review. Acta Pharm. 2011;61:117-139.
  14. Setty CM, Prasad DVK, Gupta VRM, Sa B. Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants. Ind. J Pharm Sci. 2008;70:180. Shah RB, Tawakkul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS Pharm Sci Tech. 2008;9:250-258.
  15. Elkhodairy KA, Hassan MA, Afifi SA. Formulation and optimization of orodispersible tablets of flutamide. Saudi Pharma J. 2014;22:53-61.
  16. Siddiqui MN, Garg G, Sharma PK. Fast dissolving tablets: preparation, characterization and evaluation: an overview. IJPSRR. 2010;4:87-96.
  17. Gohel MC, Parikh RK